Cardiomems

Abbott.com · United States of America

CardioMEMS is a medical device technology acquired by Abbott that provides an implantable pulmonary artery pressure monitoring system used to manage patients with heart failure. The system wirelessly transmits pressure data from a small sensor implanted in the pulmonary artery to clinicians, enabling earlier intervention and optimization of therapy. Abbott commercializes CardioMEMS through hospitals and cardiology practices as part of its cardiovascular medical devices portfolio.

Revenue
$1B+
Employees
5,001+
Founded
1888
Headquarters
United States of America

Cardiomems customers on Arbolus

Total customers 8 7 current · 1 former
Reviews growth 7 new reviews since Feb 2026

Customers who reviewed Cardiomems

Seniority of Cardiomems customers

Most people who reviewed Cardiomems hold C-Suite roles (57%), followed by Director (43%).

  • C-Suite 57%
  • Director 43%

Customers sample

Operations Leader Director NPS 10 Will renew
Other Analyst Director NPS 9
Executive C-Suite NPS 6

Employer names and spend open once the report publishes.

What 8 Arbolus experts think of Cardiomems

Overall sentiment: Positive

NPS scores range widely, from 3 (detractor) to 10 (promoter), with concentrations in the 8-10 range among high spenders and Influencers, and lower NPS among low spenders. High renewal intent aligns with high NPS and spend: both $2M+ accounts indicated continued use with NPS 10. Stickiness data shows 78% have implemented the product more than one year, reflecting strong embeddedness. Sentiment is polarized at the low spend/short tenure end, but predominantly positive among enterprise users.

Tell us when the Cardiomems report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

0 Net Promoter Score, from 8 scored reviews
  • Promoters 3
  • Passives 2
  • Detractors 3

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 67%
  • Will renew 2
  • Undecided 0
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 1 answer
  • Director 100% 2 answers
  • 10/10 Average score from customers who will renew
  • 5/10 Average score from customers not renewing

For people who use Cardiomems

Do you use Cardiomems at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 8 customers of Cardiomems have already contributed

Takes a few minutes. Your identity stays anonymous.